Objectives: Myelomeningocele is the most prevalent non-lethal central nervous system malformation and is associated to the Arnold Chiari II malformation. MOMS showed, that prenatal repair of myelomeningocele reduces the postnatal need for placement of a cerebroespinal fluid shunt, hydrocephalus, posterior fossa herniation and perinatal morbidity and mortality. The objective of this study is to describe the intrauterine imaging monitoring of posterior fossa, A. Chiari II signs after prenatal repair. Methods: Casuistry of Chilean public hospital in Valparaíso, Hospital Carlos Van Buren, is exposed. The program of prenatal myelomeningocele surgery began on December 2014 at this centre. Until the date we have performed nine ( 9) of these intervention. The inclusion criteria were singleton pregnancy, gestational age under 27 weeks and diagnosis of neural tube defect with Myelomeningocele. Post-surgical follow up was performed through Neurosonography and Fetal MRI. Results: The average gestational age at diagnosis was 22 weeks. All of these 9 fetus presented A. Chiari malformation. The prenatal surgery was carried out between week 24+5 and 27+0. There was one neonatal death at 28 weeks for chorioamnionitis. Ninth case is a still ongoing pregnancy.Mean gestational age at delivery was 32.7 weeks including the adverse event, (Rank from 28 to 37 weeks). The imaging post-surgical follow up showed objective improvement of A. Chiari in 8 survival fetus: appearance of cisterna magna, reversion of abnormal curvature of cerebellar hemispheres, decreased of ventriculomegaly, recovery of IV ventricle and less cerebellar herniation by foramen magnum is observed. Conclusions: This series of cases demonstrates improvement in the post surgical ultrasound and MRI signs of defects of the posterior fosa including A. Chiari II. These findings show a break in the natural history of the disease.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.